General Information of Drug (ID: DMF7DU6)

Drug Name
SC-005
Indication
Disease Entry ICD 11 Status REF
Triple negative breast cancer 2C60-2C65 Phase 1 [1]
Cross-matching ID
TTD ID
D0W8NB

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)